Retatrutide remains investigational as of 2026. It's not FDA-accredited and can't be prescribed or compounded outside of medical demo participation. This model circumvents conventional medical oversight while delivering illegal solutions. Individuals bear overall health hazards from most likely contaminated or mislabeled compounds even though ph